As the opioid epidemic has tightened its grip on nearly every city and state in the U.S., healthcare organizations are on the front lines of not just treating opioid addiction but clamping down on unnecessary prescriptions. 

To do this, health systems have turned to data and analytics, using state databases, e-prescribing systems and clinical decision support tools embedded into the EHR. Likewise, payers are sifting through claims data to highlight prescribing patterns. While these tools have changed the way healthcare leaders and public health officials confront the problem, integrating those solutions and bringing physicians and pharmacists on board poses a unique set of challenges.

During this webinar, our experts will discuss:

  • How hospitals and health systems are using public databases paired with analytics to understand the scope of the opioid epidemic
  • What new databases are available to draw actionable insights
  • The types of tools, including clinical decision support technology, that have had the biggest impact on changing prescribing patterns
  • The importance of integrating new prescribing tools into the physician workflow
  • Getting clinician buy-in and providing actionable data to measurably reduce unnecessary opioid prescriptions
  • How insurers are using data analytics to identify hotspots of overprescribing

Featured Speakers

Daniel Knecht, MD

Vice President, Clinical Strategy & Policy
Aetna

Dr. Knecht currently serves as vice president of clinical strategy and policy for Aetna. His responsibilities include creation and execution of Aetna’s clinical strategy which enhances the value of health care afforded to members, as well as identifying and implementing strategic initiatives, in care management, and data analytics. Dr. Knecht also provides oversight over Aetna’s Clinical Policy unit, a team that reviews clinical evidence regarding novel technologies including therapeutics, devices and diagnostics and establishes our coverage policies under the medical benefit.

Anuradha Rao-Patel, MD

Lead Medical Director, Government Programs
Blue Cross and Blue Shield of North Carolina

As lead medical director for government programs, Anuradha Rao-Patel, MD, oversees the medical directors responsible for utilization and care management activities for Medicare Advantage, Federal Employee Program, and State Health Plan lines of business at Blue Cross and Blue Shield of North Carolina. Her additional responsibilities also include the role of interim Chief Medical Officer for Healthy Blue.

Joseph Albright, PharmD

Team Lead of Clinical Pharmacy Services
Blue Cross and Blue Shield of North Carolina 

Joseph Albright joined Blue Cross and Blue Shield of North Carolina in January of 2016. He leads a high performing team that manages the clinical pharmacy programs for 1.4 Million members. His work encompasses multiple lines of business including the ACA compliant exchange market, self-insured groups, as well as North Carolina’s fully insured population. He is influential in pharmacy strategies for diabetes, opioid use, and medication assisted therapy for opioid use disorder. 

Christie Welton, PharmD

Pharmacist and Clinical Executive
Elsevier

Christie Welton is a pharmacist and Clinical Executive with Elsevier. She received her Doctor of Pharmacy degree from Butler University in Indianapolis, IN. Christie spent over a decade of her career working directly with patients and providers in the retail and specialty pharmacy space. Since 2014 she has shared her expertise on Elsevier’s drug information team, helping to bring optimal drug data solutions to healthcare organizations across the U.S.

NOW AVAILABLE ON-DEMAND

Register now for this webinar